Cambridge Investment Research Advisors’s Franklin Genomic Advancements ETF HELX Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2021 Q4	–	Sell	-8,860	Closed	-$464K	–	3218
2021 Q3	$464K	Buy	8,860 +4,720	+114%	+$247K	﹤0.01%	2104
2021 Q2	$214K	Buy	+4,140	New	+$214K	﹤0.01%	2772
2021 Q1	–	Sell	-6,580	Closed	-$291K	–	2923
2020 Q4	$291K	Buy	+6,580	New	+$291K	﹤0.01%	2166